SlideShare a Scribd company logo
Date- 02-03-2016
Presented By-
Dr. Ashutosh Kumar
AP Dept of Orthopaedics
RMCH, Bareilly.
 It is a chronic granulomatous disease caused by bacteria of
“Mycobacterium Tuberculosis” complex.
 The disease usually affects the lungs, although other organs like
viscera, spine,bone, joint, CNS, tendon sheath & bursae.
 It is transmitted through the airborne spread of droplet nuclei
produced by patient with infectious Pulmn.TB.
 If properly treated, it is curable in virtually all cases, but if
untreated, the disease may be fatal within 5 yrs in 50-60% of cases.
 Theetiological agent is ‘MycobacteriumTuberculosis complex’.
 These are aerobic, nonmotile,noncapsulated,
nonsporing.
 Theseare rod shaped of about 3 by .5 micro m in
sizeoccurring singly, in pairs or in small clumps.
 Thesearecalled acid fast baciilli or ‘AFB’.
 Theseareslowgrowing , generation timeof
about 15-20 hrs.
 Optimum temperature forgrowth is 37 deg.C
& growth does not occur < 25 deg & > 50 deg C.
 The skeletal TB is result from hematogenous dissemination from a
primarily infected focus.
 Reaches the skeletal system through arteries or in axial skeleton
through ‘Batson’s plexus of veins’.
 Simultaneous involvement of paradiscal part of 2 contiguous
vertebrae lends support to insemination of bacilli through common
blood supply to this region.
 7% of cases of spinal TB had “skipped lesion” & 12% had
involvement of other bone & joints.
 Osteo articular TB
 May resolvecompletely
 May heal completely with residualdeformity.
 The lesion may becompletelywalled off & caseous tissue may be
calcified.
 A lowgradechronic fibromatousgranulating lesion may persistwith
grumbling activity.
 The lesion mayspread locallyorsystemically in immunocompromised
patient.
 Draws the attention to a mild focus.
 May activate a latent tubercular focus.
 Repeated mechanical strain -> minor hematoma or bone marrow
edema -> determine the frequent localization.
 Human immune response is very effective for which only 5%
develops clinically evident primary disease & further 5% so develops
post primary disease.
 The helper subset of T-Lymphocytes is central to cell mediated
immunity against tuberculous infection.
 Extensive surgery & use of metal implants offered a favorable nidus
for localization of circulating mycobacteria.
 There is some inflammatory changes in the peri-implant tissue due
to immunological & macrophagic reaction offers a favorable nidus for
circulating mycobacteria.
 A)- Caseousexudative type- Characterized by more
destruction, more exudation & abscess formation.
B)- Granular type- Less destructive & abscess formation is rare.
The lesion in children is caseous exudative type, where
as in adult it is a granular type.
I Synovitis Movement > 75%, soft tissue swelling,
osteoporosis.
II Early arthritis Movement 50 – 75%, moderate diminution of joint
space & marginal erosion.
III Advanced
arthritis
Loss of movement > 75%, marked diminution of
joint space & destruction of joint surface.
IV Advanced
arthritis with
subluxation/defor
mity
Loss of movement > 75% , joint is disorganized
with subluxation / dislocation.
V Afterwarth of
gross arthritis
Gross deformity & ankylosis. Degenerative
osteoarthrosis.
I)- Central type Skipped lesion in the vertebral column,
associated with tubercular meningitis due to
spread of infection through Batson’s
perivertebral plexus of vein.
II)- Paradiscal type Vertebral lesion associated with tubercular foci in the
extremities due to spread by way of arteries.
Destruction of adjacent bone end plate &
diminution of intervening disc.
III)- Anterior type Involvement of vertebral body due to extension of
abscess beneath the anterior longitudinal ligament &
the periosteum.
IV)- Posterior type Involvement of pedicle , laminae, transverse orocess
or spinous process.
Poor socio-economic status.
Corticosteroid therapy.
Alcoholism.
Prolonged illness.
Diabetic state.
Anticancer chemotherapy.
Immunosupressive therapy.
Old age.
 Low grade fever.
 Lassitude.
 Anorexia.
 Loss of weight.
 Night sweats.
 Pain ( night cries).
 Swelling.
 Sinus formation.
 Muscle wasting.
 Tachycardia.
 Anemia.
 Regional lymph node enlargement.
 Painful limitation of movement.
> Localized osteoporosis.
> Washed out appearance of articular cartilage.
> Bony destruction & osteolysis.
> Soft tissue swelling.
> Diminution of joint space.
> Collapse, subluxation, dislocation, deformity of joint.
> Irregular growth or premature fusion.
> Coke like sequestrum.
> Subperiosteal new bone formation.
> Dystrophic calcification
> Relative lymphocytosis.
> Low Hb%.
> Raised ESR.
The test is of limited value in the diagnosis of active TB
because of its relatively low sensitivity & its specificity & its
inability to discriminate between latent infection & active disease.
Tuberculin test may be negative although active TB is
present in various conditions.
 BIOPSY-
Whenever there is doubt it is mandatory to prove the diagnosis
by obtaining the diseased tissue ( granulation/ synovium/ bone/
lymph node).
Microscoping examination of aspiration cytology, core biopsy,
needle biopsy, open biopsy would reveal typical “tubercle”.
Leucocytosis, (10 to 20 thousands per ml) in which
polymorphs predominates.
Glucose content is reduced, & protein is elevated with poor
mucin clot.
Direct smear examination of the pathological material of cases
who were not on ATT may reveal AFB-
In the synovial fluid aspirate in 10%.
In the synovial tissue in 20%.
In regional lymph node in 30%.
Culture may be positive in 30 to 60% of such material. But it generally
takes 8 weeks.
 ISOTOPE SCINTIGRAPHY-
99mTc, 67Ga, & 111In are the currently utilized isotopes.
Sensitivity is very high but lack of specificity.
A positive scan localize the suspicious region forfuture
observation & identifying an easily accessible site for tissue
diagnosis.
 SEROLOGICAL INVESTIGATION-
ELISA for antibody to mycobacterial antigen -6 has
sensitivity of 94% & specificity of 100% in the serological diagnosis
of bone & joint TB.
PCR method gives 40% sensitivity & 100 % specificity. It
may be positive even if mycobacterium is dead , formalin preserved
Or test material contain fragment of bacterium.
 CT- SCAN-
>Demonstrate small destroyed areas, marginal erosion much
before than X-ray.
> Demonstrate the soft tissue swelling.
> Good choice for detecting disease in difficult areas.
> CT guided needle biopsy is very effective for obtaining tissues
for pathological & microbiological diagnosis.
 MRI-
Shows the predestructive lesions,
Encroachment of vertebral canal, displacement of the dural sheath,
localized tuberculoma, generalized granuloma, shrinkage of the cord
substance. Myelitis can be appreciated by the study of T1 & Ta-
weighted images.
Suggest the nature
of soft tissue mass.
 USG-
Estimate the presence of soft tissue abscess & its
behavior under treatment.
May be an ideal first line investigation for tubercular
tenosynovitis.
EMOTHERAPY
Before the availability of ATT osteoarticular TB passed
through three stages spanned over a period of 3 to 5
yrs.
> Stage of onset- with localized swelling,
localized osteoporosis but minimal destruction.
> Stage of destruction- Gross destruction of joint with
deformity, subluxation, cotractures & abscess
formation. There may be dissemination of disease
which leads to death of nearly1/3rd of patient.
> Stage of repair & ankylosis- The abscess
resorbed, sinus underwent healing, remineralization of
bone & fusion & deformity of joint.
The availability of ATT (1948-51) , divides the treatment
of TB into2 eras.
(i)Pre-antitubercular era- Patient were treated either
by orthodox conservative regime or by various
operative procedure.
(ii)Post-antitubercular era- Two different lines of
treatment-
>Operative in all cases in conjunction withATT.
>ATT in all cases with operation for failure or
complications.
(B)-Supportive
> Anti- anemic
> Multivitamines
> High protein diet
> Blood transfusion.
First line Drugs Second line Drugs
Isoniazid
Rifampicin
Pyrazinamide
Ethambutol
Streptomycin
Thiacetazone
Paraaminosalicylicacid
Ethionamide
Cycloserine
Kanamycin
Amikacin
Capreomycin
Fluroquinolones
Macrolides
Rifabutin
Catagory
Cat I Sputum positive new cases
Sputum negative seriouslyill
Seriously ill extrapulmonary
PulmTB,TB meningitis,AbdominalTB, Bone & jointTB
spinalTB.
Cat II Treatmentdefalter
Treatment failure
Relapse
Cat III Smear negative new pulm.TB with limitedparenchymal
involvement.
Tubercular lymphadenitis, skinTB.
Cat IV Chronic or MDR cases
Drug Mechanism of
action
WHO
recommended
doses
Side effects
Isoniazid Bacteriocidal, Inhibits
the synthesis of
mycolic acid
5 mg/kg daily dose.
10 mg/kg 3 per wk
dose.
Peri. neuropathy,
behavior disorder,
hepatitis, convulsion
Rifampicin Bacteriocidal, Inhibit
DNA depended RNA
synthesis
10 mg/kg both daily
& 3 per wk dose
Hepatitis, pinkish
staining of urine,saliva,
flu like syndrome,
rashes
Pyrazinamid
e
Bacteriocidal, Inhibit
mycolic acid
synthesis
30-40 mg/kg Gouty arthritis,
hepatotoxicity
Ethambutol Bacteriostatic 15-20 mg/kg Retrobulbar neuritis,
loss of vision, colour
blindness.
Streptomycin Bacteriocidal &
bacteriostatic. Inhibits
the protein synthesis
15-20 mg/kg Vestibular damage,
deafness,
nephrotoxicity, contact
dermatitis.
 DOTS- Directly observed treatment short course, means
administering potent antimycobacterial regimens in an intermittent
manner under direct supervision.
 RNTCP- Revised national tuberculosis control programme
based on the DOTS strategy in 1993 & gradually expanded &
covered entire country under DOTS by 24th Mar2006.
Catagory Initial phase Continuation
phase
Duration
I 2 (HRZE)3 4 (HR)3 6 Months
II 2 ( HRZES)3 +
1 (HRZE)3
5 (HRE)3 8 Months
III 2 (HRZ)3 4 (HR)3 6 Months
 Multi-drug Resistance (MDR) TB- Defined as resistance
to Isoniazide & Rifampicin.
Treatment of MDR –TB :-
6 months of initial phase with Streptomycin +
Quinolone + Pyrazinamide + Ethambutol.
18 months of continuation phase with
Ethionamide + Quinolone + Pyrazinamide +
Ethambutol.
 Corticosteroid :-
Cortisone may help keep alive a moribund patient till theATT
can take effect.
Steroid is useful in patient with severe hypersensitivity reaction.
A short course anabolic steroid may help a debilitated patientto
be prepared for surgery.
NSAID:-
Used for relief of pain in early painful stage of disease.
 Aspiration of joint.
 Drainage of abscess.
 Excision of sinus
 INDICATION-
> If response to conservative treatment is not favorable or
outcome is unacceptable.
> No sign of neurological recovery after trial of 3-4 wks therapy.
> Neurological complication develop during conservative
treatment.
> Neuro deficit become worse on drugs & rest.
> Recurrence of neurological complication.
> Cervical abscess hampers in deglutition& respiration.
> Advanced cases sphincter involvement, flaccid paralysis,
severe flexor spasm.
Surgery Indication
Synvectomy & joint
debridement
Synovitis & Early arthitis
Osteotomy Sound or unsound ankylosis
in bad position
Arthrodesis
Ischiofemoral & Iliofemoral
Adult with unsound ankylosis
with active or healed disease
Excisional Arthroplasty
( Girdlestone’s)
Sound or unsound ankylosis.
 Disappearance of all systemic & local features
 Return of painless motion.
 Repeated ESR is normal & no progression.
 Remineralization & restoration of bony outline.
 Resolution of edema & soft tissue swelling.
 Bony alkylosis.
Immuno-prophylaxis-
0.1 ml intradermal injection of live attenuated BCG vaccine proximal
to the insertion of deltoid after birth.
Give protection upto 80% & immunity lasts for 10-15 yrs.
Chemoprophylaxis:-
Combination of Isoniazid & Ethambutol once daily dose for 4-6 months.
Indications-
>Close contacts
> Person with +ive tuberculin test .
>TB infected person without active disease but develop high
risk condition.
> Patient with old inactive disease who are assessed to have
received inadequate therapy.
General outline of musculoskeletal tuberculosis by dr ashutosh
General outline of musculoskeletal tuberculosis by dr ashutosh

More Related Content

What's hot

general principle of bone tumour
general principle of bone tumourgeneral principle of bone tumour
general principle of bone tumour
Dr Sharanprasad Hongal
 
Non union
Non unionNon union
Non union
Alla Kumar
 
Masquelet technique ppt
Masquelet technique pptMasquelet technique ppt
Masquelet technique ppt
Apoorv Garg
 
Kienbock Disease
Kienbock DiseaseKienbock Disease
Kienbock Disease
drmbhama
 
Cable techniques for bone transport in massive bone defects #dr_azanki
Cable techniques for bone transport in massive bone defects  #dr_azankiCable techniques for bone transport in massive bone defects  #dr_azanki
Cable techniques for bone transport in massive bone defects #dr_azanki
Abdallah El-Azanki
 
The AAA-Triple A total ankle arthroplasty
The AAA-Triple A total ankle arthroplastyThe AAA-Triple A total ankle arthroplasty
The AAA-Triple A total ankle arthroplasty
Ron Woering
 
Poller or blocking screw
Poller or blocking screwPoller or blocking screw
Poller or blocking screw
Avik Sarkar
 
Calcaneal fractures new
Calcaneal fractures newCalcaneal fractures new
Calcaneal fractures new
Thanh Nguyen
 
Distal femur fractures dr.shubham.pptx
Distal femur fractures dr.shubham.pptxDistal femur fractures dr.shubham.pptx
Distal femur fractures dr.shubham.pptx
EetaJain1
 
antibiotic coated nails in orthopedic, antibiotic nail
antibiotic coated nails in orthopedic, antibiotic nail antibiotic coated nails in orthopedic, antibiotic nail
antibiotic coated nails in orthopedic, antibiotic nail
yashavardhan yashu
 
Infected nonunion tibia
Infected  nonunion tibiaInfected  nonunion tibia
Infected nonunion tibia
anand mishra
 
Tendon injuries of hand
Tendon injuries of handTendon injuries of hand
Tendon injuries of hand
rohit raj
 
Uncemented femoral stem
Uncemented  femoral stemUncemented  femoral stem
Uncemented femoral stem
Sameer Ashar
 
Evolution of Intramedullary Nails
Evolution of Intramedullary NailsEvolution of Intramedullary Nails
Evolution of Intramedullary Nails
Prateek Goel
 
Non union scaphoid 1
Non union scaphoid 1Non union scaphoid 1
Non union scaphoid 1
Benthungo Tungoe
 
Bio degadable implants used in Orthopaedics by Dr.Vinay
Bio degadable implants used in Orthopaedics by Dr.VinayBio degadable implants used in Orthopaedics by Dr.Vinay
Bio degadable implants used in Orthopaedics by Dr.Vinay
Venkat Vinay
 
Acl graft fixation options
Acl graft fixation optionsAcl graft fixation options
Acl graft fixation options
orthoprinciples
 
Management of Cartilage injuries
Management of Cartilage injuriesManagement of Cartilage injuries
Management of Cartilage injuries
Shankar Sanu
 
Proximal tibia fractures(Plateau, spine ,Tubercle and Epiphyseal )
Proximal tibia fractures(Plateau, spine ,Tubercle and Epiphyseal ) Proximal tibia fractures(Plateau, spine ,Tubercle and Epiphyseal )
Proximal tibia fractures(Plateau, spine ,Tubercle and Epiphyseal )
Prasanthmuddada
 
Ilizarov Instrumentation 2-2.pdf
Ilizarov Instrumentation 2-2.pdfIlizarov Instrumentation 2-2.pdf
Ilizarov Instrumentation 2-2.pdf
GMC amritsar
 

What's hot (20)

general principle of bone tumour
general principle of bone tumourgeneral principle of bone tumour
general principle of bone tumour
 
Non union
Non unionNon union
Non union
 
Masquelet technique ppt
Masquelet technique pptMasquelet technique ppt
Masquelet technique ppt
 
Kienbock Disease
Kienbock DiseaseKienbock Disease
Kienbock Disease
 
Cable techniques for bone transport in massive bone defects #dr_azanki
Cable techniques for bone transport in massive bone defects  #dr_azankiCable techniques for bone transport in massive bone defects  #dr_azanki
Cable techniques for bone transport in massive bone defects #dr_azanki
 
The AAA-Triple A total ankle arthroplasty
The AAA-Triple A total ankle arthroplastyThe AAA-Triple A total ankle arthroplasty
The AAA-Triple A total ankle arthroplasty
 
Poller or blocking screw
Poller or blocking screwPoller or blocking screw
Poller or blocking screw
 
Calcaneal fractures new
Calcaneal fractures newCalcaneal fractures new
Calcaneal fractures new
 
Distal femur fractures dr.shubham.pptx
Distal femur fractures dr.shubham.pptxDistal femur fractures dr.shubham.pptx
Distal femur fractures dr.shubham.pptx
 
antibiotic coated nails in orthopedic, antibiotic nail
antibiotic coated nails in orthopedic, antibiotic nail antibiotic coated nails in orthopedic, antibiotic nail
antibiotic coated nails in orthopedic, antibiotic nail
 
Infected nonunion tibia
Infected  nonunion tibiaInfected  nonunion tibia
Infected nonunion tibia
 
Tendon injuries of hand
Tendon injuries of handTendon injuries of hand
Tendon injuries of hand
 
Uncemented femoral stem
Uncemented  femoral stemUncemented  femoral stem
Uncemented femoral stem
 
Evolution of Intramedullary Nails
Evolution of Intramedullary NailsEvolution of Intramedullary Nails
Evolution of Intramedullary Nails
 
Non union scaphoid 1
Non union scaphoid 1Non union scaphoid 1
Non union scaphoid 1
 
Bio degadable implants used in Orthopaedics by Dr.Vinay
Bio degadable implants used in Orthopaedics by Dr.VinayBio degadable implants used in Orthopaedics by Dr.Vinay
Bio degadable implants used in Orthopaedics by Dr.Vinay
 
Acl graft fixation options
Acl graft fixation optionsAcl graft fixation options
Acl graft fixation options
 
Management of Cartilage injuries
Management of Cartilage injuriesManagement of Cartilage injuries
Management of Cartilage injuries
 
Proximal tibia fractures(Plateau, spine ,Tubercle and Epiphyseal )
Proximal tibia fractures(Plateau, spine ,Tubercle and Epiphyseal ) Proximal tibia fractures(Plateau, spine ,Tubercle and Epiphyseal )
Proximal tibia fractures(Plateau, spine ,Tubercle and Epiphyseal )
 
Ilizarov Instrumentation 2-2.pdf
Ilizarov Instrumentation 2-2.pdfIlizarov Instrumentation 2-2.pdf
Ilizarov Instrumentation 2-2.pdf
 

Similar to General outline of musculoskeletal tuberculosis by dr ashutosh

Seminar on tb
Seminar on tbSeminar on tb
Seminar on tb
DrSiddique H. Ranna
 
Shah alam sir om (2)
Shah alam sir om (2)Shah alam sir om (2)
Shah alam sir om (2)
wasek_bd
 
Acute and sub-acute Osteomyelitis
Acute and sub-acute OsteomyelitisAcute and sub-acute Osteomyelitis
Acute and sub-acute Osteomyelitis
AIIMS Bhopal
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
BhaskarRaJ14
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Paediatric musculoskeletal infections
Paediatric musculoskeletal infectionsPaediatric musculoskeletal infections
Paediatric musculoskeletal infections
RITESHJAISWAL57
 
Bone Infections
Bone InfectionsBone Infections
Bone Infections
Dr-Amr Abualrub
 
Chronic Osteomyelitis In Children
Chronic Osteomyelitis In ChildrenChronic Osteomyelitis In Children
Chronic Osteomyelitis In Children
Vasu Rao kaza
 
Infected n u
Infected n uInfected n u
Infected n u
Dr Imran Jan
 
Orthopedics 5th year, 4th lecture (Dr. Hamid)
Orthopedics 5th year, 4th lecture (Dr. Hamid)Orthopedics 5th year, 4th lecture (Dr. Hamid)
Orthopedics 5th year, 4th lecture (Dr. Hamid)
College of Medicine, Sulaymaniyah
 
Infected nonunion2
Infected nonunion2Infected nonunion2
Infected nonunion2
orthoprince
 
Giant cell tumor
Giant cell tumorGiant cell tumor
Giant cell tumor
Sudheer Kumar
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
group7usmkk
 
Ewings sarcoma_UTSAV
Ewings sarcoma_UTSAVEwings sarcoma_UTSAV
Ewings sarcoma_UTSAV
Utsav Agrawal
 
Ewings sarcoma_utsav
Ewings sarcoma_utsavEwings sarcoma_utsav
Ewings sarcoma_utsav
Utsav Agrawal
 
Ewings sarcoma_UTSAV
Ewings sarcoma_UTSAVEwings sarcoma_UTSAV
Ewings sarcoma_UTSAV
Utsav Agrawal
 
Acute and Chronic Osteomyelitis - Infection of Bone
Acute and Chronic Osteomyelitis - Infection of BoneAcute and Chronic Osteomyelitis - Infection of Bone
Acute and Chronic Osteomyelitis - Infection of Bone
Rahul Singh
 
Pyogenic bone and joint infections
Pyogenic bone and joint infectionsPyogenic bone and joint infections
Pyogenic bone and joint infections
Bajanagaraju
 
osteomyelitisbydr-171123063448.pptx
osteomyelitisbydr-171123063448.pptxosteomyelitisbydr-171123063448.pptx
osteomyelitisbydr-171123063448.pptx
AmerManzoorPak
 
osteomyelitis-130708212636-phpapp01 (1).pptx
osteomyelitis-130708212636-phpapp01 (1).pptxosteomyelitis-130708212636-phpapp01 (1).pptx
osteomyelitis-130708212636-phpapp01 (1).pptx
sonalidas935894
 

Similar to General outline of musculoskeletal tuberculosis by dr ashutosh (20)

Seminar on tb
Seminar on tbSeminar on tb
Seminar on tb
 
Shah alam sir om (2)
Shah alam sir om (2)Shah alam sir om (2)
Shah alam sir om (2)
 
Acute and sub-acute Osteomyelitis
Acute and sub-acute OsteomyelitisAcute and sub-acute Osteomyelitis
Acute and sub-acute Osteomyelitis
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
Paediatric musculoskeletal infections
Paediatric musculoskeletal infectionsPaediatric musculoskeletal infections
Paediatric musculoskeletal infections
 
Bone Infections
Bone InfectionsBone Infections
Bone Infections
 
Chronic Osteomyelitis In Children
Chronic Osteomyelitis In ChildrenChronic Osteomyelitis In Children
Chronic Osteomyelitis In Children
 
Infected n u
Infected n uInfected n u
Infected n u
 
Orthopedics 5th year, 4th lecture (Dr. Hamid)
Orthopedics 5th year, 4th lecture (Dr. Hamid)Orthopedics 5th year, 4th lecture (Dr. Hamid)
Orthopedics 5th year, 4th lecture (Dr. Hamid)
 
Infected nonunion2
Infected nonunion2Infected nonunion2
Infected nonunion2
 
Giant cell tumor
Giant cell tumorGiant cell tumor
Giant cell tumor
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
Ewings sarcoma_UTSAV
Ewings sarcoma_UTSAVEwings sarcoma_UTSAV
Ewings sarcoma_UTSAV
 
Ewings sarcoma_utsav
Ewings sarcoma_utsavEwings sarcoma_utsav
Ewings sarcoma_utsav
 
Ewings sarcoma_UTSAV
Ewings sarcoma_UTSAVEwings sarcoma_UTSAV
Ewings sarcoma_UTSAV
 
Acute and Chronic Osteomyelitis - Infection of Bone
Acute and Chronic Osteomyelitis - Infection of BoneAcute and Chronic Osteomyelitis - Infection of Bone
Acute and Chronic Osteomyelitis - Infection of Bone
 
Pyogenic bone and joint infections
Pyogenic bone and joint infectionsPyogenic bone and joint infections
Pyogenic bone and joint infections
 
osteomyelitisbydr-171123063448.pptx
osteomyelitisbydr-171123063448.pptxosteomyelitisbydr-171123063448.pptx
osteomyelitisbydr-171123063448.pptx
 
osteomyelitis-130708212636-phpapp01 (1).pptx
osteomyelitis-130708212636-phpapp01 (1).pptxosteomyelitis-130708212636-phpapp01 (1).pptx
osteomyelitis-130708212636-phpapp01 (1).pptx
 

More from Ashutosh Kumar

Gout
GoutGout
Fracture calcaneum and talus by dr ashutosh
Fracture calcaneum and talus by dr ashutoshFracture calcaneum and talus by dr ashutosh
Fracture calcaneum and talus by dr ashutosh
Ashutosh Kumar
 
Tuberculosis of knee by dr ashutosh
Tuberculosis of knee by dr ashutoshTuberculosis of knee by dr ashutosh
Tuberculosis of knee by dr ashutosh
Ashutosh Kumar
 
Traumatic paraplegia & bladder management by dr ashutosh
Traumatic paraplegia & bladder management by dr ashutoshTraumatic paraplegia & bladder management by dr ashutosh
Traumatic paraplegia & bladder management by dr ashutosh
Ashutosh Kumar
 
Tb hip
Tb hipTb hip
Pottsspine &amp; paraplegia by dr ashutosh
Pottsspine &amp; paraplegia by dr ashutoshPottsspine &amp; paraplegia by dr ashutosh
Pottsspine &amp; paraplegia by dr ashutosh
Ashutosh Kumar
 
Peripheral nerve injury by dr ashutosh
Peripheral nerve injury by dr ashutoshPeripheral nerve injury by dr ashutosh
Peripheral nerve injury by dr ashutosh
Ashutosh Kumar
 
Humerusfracture 170427173809-converted
Humerusfracture 170427173809-convertedHumerusfracture 170427173809-converted
Humerusfracture 170427173809-converted
Ashutosh Kumar
 
Humerus shaft fracture and elbow dislocation by dr ashutosh
Humerus shaft fracture and elbow dislocation by dr ashutoshHumerus shaft fracture and elbow dislocation by dr ashutosh
Humerus shaft fracture and elbow dislocation by dr ashutosh
Ashutosh Kumar
 
Fracture shaft of femur by dr ashutosh
Fracture shaft of femur by dr ashutoshFracture shaft of femur by dr ashutosh
Fracture shaft of femur by dr ashutosh
Ashutosh Kumar
 
Distal humerus fracture in pediatrics by dr ashutosh
Distal humerus fracture in pediatrics by dr ashutoshDistal humerus fracture in pediatrics by dr ashutosh
Distal humerus fracture in pediatrics by dr ashutosh
Ashutosh Kumar
 
Distal humerus fracture and elbow dislocation by dr ashutosh
Distal humerus fracture and elbow dislocation by dr ashutoshDistal humerus fracture and elbow dislocation by dr ashutosh
Distal humerus fracture and elbow dislocation by dr ashutosh
Ashutosh Kumar
 
Distal femur fractures &amp; fracture patella by dr ashutosh
Distal femur fractures &amp; fracture patella by dr ashutoshDistal femur fractures &amp; fracture patella by dr ashutosh
Distal femur fractures &amp; fracture patella by dr ashutosh
Ashutosh Kumar
 
Ankylosing spondylitis by dr ashutosh
Ankylosing spondylitis by dr ashutoshAnkylosing spondylitis by dr ashutosh
Ankylosing spondylitis by dr ashutosh
Ashutosh Kumar
 
Acute pyogenic arthritis by dr ashutosh
Acute pyogenic arthritis by dr ashutoshAcute pyogenic arthritis by dr ashutosh
Acute pyogenic arthritis by dr ashutosh
Ashutosh Kumar
 

More from Ashutosh Kumar (15)

Gout
GoutGout
Gout
 
Fracture calcaneum and talus by dr ashutosh
Fracture calcaneum and talus by dr ashutoshFracture calcaneum and talus by dr ashutosh
Fracture calcaneum and talus by dr ashutosh
 
Tuberculosis of knee by dr ashutosh
Tuberculosis of knee by dr ashutoshTuberculosis of knee by dr ashutosh
Tuberculosis of knee by dr ashutosh
 
Traumatic paraplegia & bladder management by dr ashutosh
Traumatic paraplegia & bladder management by dr ashutoshTraumatic paraplegia & bladder management by dr ashutosh
Traumatic paraplegia & bladder management by dr ashutosh
 
Tb hip
Tb hipTb hip
Tb hip
 
Pottsspine &amp; paraplegia by dr ashutosh
Pottsspine &amp; paraplegia by dr ashutoshPottsspine &amp; paraplegia by dr ashutosh
Pottsspine &amp; paraplegia by dr ashutosh
 
Peripheral nerve injury by dr ashutosh
Peripheral nerve injury by dr ashutoshPeripheral nerve injury by dr ashutosh
Peripheral nerve injury by dr ashutosh
 
Humerusfracture 170427173809-converted
Humerusfracture 170427173809-convertedHumerusfracture 170427173809-converted
Humerusfracture 170427173809-converted
 
Humerus shaft fracture and elbow dislocation by dr ashutosh
Humerus shaft fracture and elbow dislocation by dr ashutoshHumerus shaft fracture and elbow dislocation by dr ashutosh
Humerus shaft fracture and elbow dislocation by dr ashutosh
 
Fracture shaft of femur by dr ashutosh
Fracture shaft of femur by dr ashutoshFracture shaft of femur by dr ashutosh
Fracture shaft of femur by dr ashutosh
 
Distal humerus fracture in pediatrics by dr ashutosh
Distal humerus fracture in pediatrics by dr ashutoshDistal humerus fracture in pediatrics by dr ashutosh
Distal humerus fracture in pediatrics by dr ashutosh
 
Distal humerus fracture and elbow dislocation by dr ashutosh
Distal humerus fracture and elbow dislocation by dr ashutoshDistal humerus fracture and elbow dislocation by dr ashutosh
Distal humerus fracture and elbow dislocation by dr ashutosh
 
Distal femur fractures &amp; fracture patella by dr ashutosh
Distal femur fractures &amp; fracture patella by dr ashutoshDistal femur fractures &amp; fracture patella by dr ashutosh
Distal femur fractures &amp; fracture patella by dr ashutosh
 
Ankylosing spondylitis by dr ashutosh
Ankylosing spondylitis by dr ashutoshAnkylosing spondylitis by dr ashutosh
Ankylosing spondylitis by dr ashutosh
 
Acute pyogenic arthritis by dr ashutosh
Acute pyogenic arthritis by dr ashutoshAcute pyogenic arthritis by dr ashutosh
Acute pyogenic arthritis by dr ashutosh
 

Recently uploaded

Carrer goals.pptx and their importance in real life
Carrer goals.pptx  and their importance in real lifeCarrer goals.pptx  and their importance in real life
Carrer goals.pptx and their importance in real life
artemacademy2
 
2024-05-30_meetup_devops_aix-marseille.pdf
2024-05-30_meetup_devops_aix-marseille.pdf2024-05-30_meetup_devops_aix-marseille.pdf
2024-05-30_meetup_devops_aix-marseille.pdf
Frederic Leger
 
ASONAM2023_presection_slide_track-recommendation.pdf
ASONAM2023_presection_slide_track-recommendation.pdfASONAM2023_presection_slide_track-recommendation.pdf
ASONAM2023_presection_slide_track-recommendation.pdf
ToshihiroIto4
 
Mẫu PPT kế hoạch làm việc sáng tạo cho nửa cuối năm PowerPoint
Mẫu PPT kế hoạch làm việc sáng tạo cho nửa cuối năm PowerPointMẫu PPT kế hoạch làm việc sáng tạo cho nửa cuối năm PowerPoint
Mẫu PPT kế hoạch làm việc sáng tạo cho nửa cuối năm PowerPoint
1990 Media
 
Artificial Intelligence, Data and Competition – OECD – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – OECD – June 2024 OECD discussionArtificial Intelligence, Data and Competition – OECD – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – OECD – June 2024 OECD discussion
OECD Directorate for Financial and Enterprise Affairs
 
XP 2024 presentation: A New Look to Leadership
XP 2024 presentation: A New Look to LeadershipXP 2024 presentation: A New Look to Leadership
XP 2024 presentation: A New Look to Leadership
samililja
 
Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...
Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...
Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...
OECD Directorate for Financial and Enterprise Affairs
 
Tom tresser burning issue.pptx My Burning issue
Tom tresser burning issue.pptx My Burning issueTom tresser burning issue.pptx My Burning issue
Tom tresser burning issue.pptx My Burning issue
amekonnen
 
Presentatie 4. Jochen Cremer - TU Delft 28 mei 2024
Presentatie 4. Jochen Cremer - TU Delft 28 mei 2024Presentatie 4. Jochen Cremer - TU Delft 28 mei 2024
Presentatie 4. Jochen Cremer - TU Delft 28 mei 2024
Dutch Power
 
Presentatie 8. Joost van der Linde & Daniel Anderton - Eliq 28 mei 2024
Presentatie 8. Joost van der Linde & Daniel Anderton - Eliq 28 mei 2024Presentatie 8. Joost van der Linde & Daniel Anderton - Eliq 28 mei 2024
Presentatie 8. Joost van der Linde & Daniel Anderton - Eliq 28 mei 2024
Dutch Power
 
Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...
Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...
Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...
Suzanne Lagerweij
 
Artificial Intelligence, Data and Competition – LIM – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – LIM – June 2024 OECD discussionArtificial Intelligence, Data and Competition – LIM – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – LIM – June 2024 OECD discussion
OECD Directorate for Financial and Enterprise Affairs
 
Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...
Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...
Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...
OECD Directorate for Financial and Enterprise Affairs
 
Mastering the Concepts Tested in the Databricks Certified Data Engineer Assoc...
Mastering the Concepts Tested in the Databricks Certified Data Engineer Assoc...Mastering the Concepts Tested in the Databricks Certified Data Engineer Assoc...
Mastering the Concepts Tested in the Databricks Certified Data Engineer Assoc...
SkillCertProExams
 
Pro-competitive Industrial Policy – LANE – June 2024 OECD discussion
Pro-competitive Industrial Policy – LANE – June 2024 OECD discussionPro-competitive Industrial Policy – LANE – June 2024 OECD discussion
Pro-competitive Industrial Policy – LANE – June 2024 OECD discussion
OECD Directorate for Financial and Enterprise Affairs
 
Collapsing Narratives: Exploring Non-Linearity • a micro report by Rosie Wells
Collapsing Narratives: Exploring Non-Linearity • a micro report by Rosie WellsCollapsing Narratives: Exploring Non-Linearity • a micro report by Rosie Wells
Collapsing Narratives: Exploring Non-Linearity • a micro report by Rosie Wells
Rosie Wells
 
Gregory Harris - Cycle 2 - Civics Presentation
Gregory Harris - Cycle 2 - Civics PresentationGregory Harris - Cycle 2 - Civics Presentation
Gregory Harris - Cycle 2 - Civics Presentation
gharris9
 
原版制作贝德福特大学毕业证(bedfordhire毕业证)硕士文凭原版一模一样
原版制作贝德福特大学毕业证(bedfordhire毕业证)硕士文凭原版一模一样原版制作贝德福特大学毕业证(bedfordhire毕业证)硕士文凭原版一模一样
原版制作贝德福特大学毕业证(bedfordhire毕业证)硕士文凭原版一模一样
gpww3sf4
 
Burning Issue Presentation By Kenmaryon.pdf
Burning Issue Presentation By Kenmaryon.pdfBurning Issue Presentation By Kenmaryon.pdf
Burning Issue Presentation By Kenmaryon.pdf
kkirkland2
 
Gregory Harris' Civics Presentation.pptx
Gregory Harris' Civics Presentation.pptxGregory Harris' Civics Presentation.pptx
Gregory Harris' Civics Presentation.pptx
gharris9
 

Recently uploaded (20)

Carrer goals.pptx and their importance in real life
Carrer goals.pptx  and their importance in real lifeCarrer goals.pptx  and their importance in real life
Carrer goals.pptx and their importance in real life
 
2024-05-30_meetup_devops_aix-marseille.pdf
2024-05-30_meetup_devops_aix-marseille.pdf2024-05-30_meetup_devops_aix-marseille.pdf
2024-05-30_meetup_devops_aix-marseille.pdf
 
ASONAM2023_presection_slide_track-recommendation.pdf
ASONAM2023_presection_slide_track-recommendation.pdfASONAM2023_presection_slide_track-recommendation.pdf
ASONAM2023_presection_slide_track-recommendation.pdf
 
Mẫu PPT kế hoạch làm việc sáng tạo cho nửa cuối năm PowerPoint
Mẫu PPT kế hoạch làm việc sáng tạo cho nửa cuối năm PowerPointMẫu PPT kế hoạch làm việc sáng tạo cho nửa cuối năm PowerPoint
Mẫu PPT kế hoạch làm việc sáng tạo cho nửa cuối năm PowerPoint
 
Artificial Intelligence, Data and Competition – OECD – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – OECD – June 2024 OECD discussionArtificial Intelligence, Data and Competition – OECD – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – OECD – June 2024 OECD discussion
 
XP 2024 presentation: A New Look to Leadership
XP 2024 presentation: A New Look to LeadershipXP 2024 presentation: A New Look to Leadership
XP 2024 presentation: A New Look to Leadership
 
Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...
Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...
Artificial Intelligence, Data and Competition – SCHREPEL – June 2024 OECD dis...
 
Tom tresser burning issue.pptx My Burning issue
Tom tresser burning issue.pptx My Burning issueTom tresser burning issue.pptx My Burning issue
Tom tresser burning issue.pptx My Burning issue
 
Presentatie 4. Jochen Cremer - TU Delft 28 mei 2024
Presentatie 4. Jochen Cremer - TU Delft 28 mei 2024Presentatie 4. Jochen Cremer - TU Delft 28 mei 2024
Presentatie 4. Jochen Cremer - TU Delft 28 mei 2024
 
Presentatie 8. Joost van der Linde & Daniel Anderton - Eliq 28 mei 2024
Presentatie 8. Joost van der Linde & Daniel Anderton - Eliq 28 mei 2024Presentatie 8. Joost van der Linde & Daniel Anderton - Eliq 28 mei 2024
Presentatie 8. Joost van der Linde & Daniel Anderton - Eliq 28 mei 2024
 
Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...
Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...
Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...
 
Artificial Intelligence, Data and Competition – LIM – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – LIM – June 2024 OECD discussionArtificial Intelligence, Data and Competition – LIM – June 2024 OECD discussion
Artificial Intelligence, Data and Competition – LIM – June 2024 OECD discussion
 
Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...
Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...
Artificial Intelligence, Data and Competition – ČORBA – June 2024 OECD discus...
 
Mastering the Concepts Tested in the Databricks Certified Data Engineer Assoc...
Mastering the Concepts Tested in the Databricks Certified Data Engineer Assoc...Mastering the Concepts Tested in the Databricks Certified Data Engineer Assoc...
Mastering the Concepts Tested in the Databricks Certified Data Engineer Assoc...
 
Pro-competitive Industrial Policy – LANE – June 2024 OECD discussion
Pro-competitive Industrial Policy – LANE – June 2024 OECD discussionPro-competitive Industrial Policy – LANE – June 2024 OECD discussion
Pro-competitive Industrial Policy – LANE – June 2024 OECD discussion
 
Collapsing Narratives: Exploring Non-Linearity • a micro report by Rosie Wells
Collapsing Narratives: Exploring Non-Linearity • a micro report by Rosie WellsCollapsing Narratives: Exploring Non-Linearity • a micro report by Rosie Wells
Collapsing Narratives: Exploring Non-Linearity • a micro report by Rosie Wells
 
Gregory Harris - Cycle 2 - Civics Presentation
Gregory Harris - Cycle 2 - Civics PresentationGregory Harris - Cycle 2 - Civics Presentation
Gregory Harris - Cycle 2 - Civics Presentation
 
原版制作贝德福特大学毕业证(bedfordhire毕业证)硕士文凭原版一模一样
原版制作贝德福特大学毕业证(bedfordhire毕业证)硕士文凭原版一模一样原版制作贝德福特大学毕业证(bedfordhire毕业证)硕士文凭原版一模一样
原版制作贝德福特大学毕业证(bedfordhire毕业证)硕士文凭原版一模一样
 
Burning Issue Presentation By Kenmaryon.pdf
Burning Issue Presentation By Kenmaryon.pdfBurning Issue Presentation By Kenmaryon.pdf
Burning Issue Presentation By Kenmaryon.pdf
 
Gregory Harris' Civics Presentation.pptx
Gregory Harris' Civics Presentation.pptxGregory Harris' Civics Presentation.pptx
Gregory Harris' Civics Presentation.pptx
 

General outline of musculoskeletal tuberculosis by dr ashutosh

  • 1. Date- 02-03-2016 Presented By- Dr. Ashutosh Kumar AP Dept of Orthopaedics RMCH, Bareilly.
  • 2.  It is a chronic granulomatous disease caused by bacteria of “Mycobacterium Tuberculosis” complex.  The disease usually affects the lungs, although other organs like viscera, spine,bone, joint, CNS, tendon sheath & bursae.  It is transmitted through the airborne spread of droplet nuclei produced by patient with infectious Pulmn.TB.  If properly treated, it is curable in virtually all cases, but if untreated, the disease may be fatal within 5 yrs in 50-60% of cases.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.  Theetiological agent is ‘MycobacteriumTuberculosis complex’.  These are aerobic, nonmotile,noncapsulated, nonsporing.  Theseare rod shaped of about 3 by .5 micro m in sizeoccurring singly, in pairs or in small clumps.  Thesearecalled acid fast baciilli or ‘AFB’.  Theseareslowgrowing , generation timeof about 15-20 hrs.  Optimum temperature forgrowth is 37 deg.C & growth does not occur < 25 deg & > 50 deg C.
  • 8.  The skeletal TB is result from hematogenous dissemination from a primarily infected focus.  Reaches the skeletal system through arteries or in axial skeleton through ‘Batson’s plexus of veins’.  Simultaneous involvement of paradiscal part of 2 contiguous vertebrae lends support to insemination of bacilli through common blood supply to this region.  7% of cases of spinal TB had “skipped lesion” & 12% had involvement of other bone & joints.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.  May resolvecompletely  May heal completely with residualdeformity.  The lesion may becompletelywalled off & caseous tissue may be calcified.  A lowgradechronic fibromatousgranulating lesion may persistwith grumbling activity.  The lesion mayspread locallyorsystemically in immunocompromised patient.
  • 15.  Draws the attention to a mild focus.  May activate a latent tubercular focus.  Repeated mechanical strain -> minor hematoma or bone marrow edema -> determine the frequent localization.
  • 16.  Human immune response is very effective for which only 5% develops clinically evident primary disease & further 5% so develops post primary disease.  The helper subset of T-Lymphocytes is central to cell mediated immunity against tuberculous infection.
  • 17.  Extensive surgery & use of metal implants offered a favorable nidus for localization of circulating mycobacteria.  There is some inflammatory changes in the peri-implant tissue due to immunological & macrophagic reaction offers a favorable nidus for circulating mycobacteria.
  • 18.  A)- Caseousexudative type- Characterized by more destruction, more exudation & abscess formation. B)- Granular type- Less destructive & abscess formation is rare. The lesion in children is caseous exudative type, where as in adult it is a granular type.
  • 19. I Synovitis Movement > 75%, soft tissue swelling, osteoporosis. II Early arthritis Movement 50 – 75%, moderate diminution of joint space & marginal erosion. III Advanced arthritis Loss of movement > 75%, marked diminution of joint space & destruction of joint surface. IV Advanced arthritis with subluxation/defor mity Loss of movement > 75% , joint is disorganized with subluxation / dislocation. V Afterwarth of gross arthritis Gross deformity & ankylosis. Degenerative osteoarthrosis.
  • 20. I)- Central type Skipped lesion in the vertebral column, associated with tubercular meningitis due to spread of infection through Batson’s perivertebral plexus of vein. II)- Paradiscal type Vertebral lesion associated with tubercular foci in the extremities due to spread by way of arteries. Destruction of adjacent bone end plate & diminution of intervening disc. III)- Anterior type Involvement of vertebral body due to extension of abscess beneath the anterior longitudinal ligament & the periosteum. IV)- Posterior type Involvement of pedicle , laminae, transverse orocess or spinous process.
  • 21.
  • 22.
  • 23. Poor socio-economic status. Corticosteroid therapy. Alcoholism. Prolonged illness. Diabetic state. Anticancer chemotherapy. Immunosupressive therapy. Old age.
  • 24.  Low grade fever.  Lassitude.  Anorexia.  Loss of weight.  Night sweats.  Pain ( night cries).  Swelling.  Sinus formation.  Muscle wasting.  Tachycardia.  Anemia.  Regional lymph node enlargement.  Painful limitation of movement.
  • 25. > Localized osteoporosis. > Washed out appearance of articular cartilage. > Bony destruction & osteolysis. > Soft tissue swelling. > Diminution of joint space. > Collapse, subluxation, dislocation, deformity of joint. > Irregular growth or premature fusion. > Coke like sequestrum. > Subperiosteal new bone formation. > Dystrophic calcification
  • 26.
  • 27. > Relative lymphocytosis. > Low Hb%. > Raised ESR. The test is of limited value in the diagnosis of active TB because of its relatively low sensitivity & its specificity & its inability to discriminate between latent infection & active disease. Tuberculin test may be negative although active TB is present in various conditions.
  • 28.  BIOPSY- Whenever there is doubt it is mandatory to prove the diagnosis by obtaining the diseased tissue ( granulation/ synovium/ bone/ lymph node). Microscoping examination of aspiration cytology, core biopsy, needle biopsy, open biopsy would reveal typical “tubercle”.
  • 29. Leucocytosis, (10 to 20 thousands per ml) in which polymorphs predominates. Glucose content is reduced, & protein is elevated with poor mucin clot.
  • 30. Direct smear examination of the pathological material of cases who were not on ATT may reveal AFB- In the synovial fluid aspirate in 10%. In the synovial tissue in 20%. In regional lymph node in 30%. Culture may be positive in 30 to 60% of such material. But it generally takes 8 weeks.
  • 31.  ISOTOPE SCINTIGRAPHY- 99mTc, 67Ga, & 111In are the currently utilized isotopes. Sensitivity is very high but lack of specificity. A positive scan localize the suspicious region forfuture observation & identifying an easily accessible site for tissue diagnosis.
  • 32.  SEROLOGICAL INVESTIGATION- ELISA for antibody to mycobacterial antigen -6 has sensitivity of 94% & specificity of 100% in the serological diagnosis of bone & joint TB. PCR method gives 40% sensitivity & 100 % specificity. It may be positive even if mycobacterium is dead , formalin preserved Or test material contain fragment of bacterium.
  • 33.  CT- SCAN- >Demonstrate small destroyed areas, marginal erosion much before than X-ray. > Demonstrate the soft tissue swelling. > Good choice for detecting disease in difficult areas. > CT guided needle biopsy is very effective for obtaining tissues for pathological & microbiological diagnosis.
  • 34.  MRI- Shows the predestructive lesions, Encroachment of vertebral canal, displacement of the dural sheath, localized tuberculoma, generalized granuloma, shrinkage of the cord substance. Myelitis can be appreciated by the study of T1 & Ta- weighted images. Suggest the nature of soft tissue mass.
  • 35.  USG- Estimate the presence of soft tissue abscess & its behavior under treatment. May be an ideal first line investigation for tubercular tenosynovitis.
  • 36. EMOTHERAPY Before the availability of ATT osteoarticular TB passed through three stages spanned over a period of 3 to 5 yrs. > Stage of onset- with localized swelling, localized osteoporosis but minimal destruction. > Stage of destruction- Gross destruction of joint with deformity, subluxation, cotractures & abscess formation. There may be dissemination of disease which leads to death of nearly1/3rd of patient. > Stage of repair & ankylosis- The abscess resorbed, sinus underwent healing, remineralization of bone & fusion & deformity of joint.
  • 37. The availability of ATT (1948-51) , divides the treatment of TB into2 eras. (i)Pre-antitubercular era- Patient were treated either by orthodox conservative regime or by various operative procedure. (ii)Post-antitubercular era- Two different lines of treatment- >Operative in all cases in conjunction withATT. >ATT in all cases with operation for failure or complications.
  • 38. (B)-Supportive > Anti- anemic > Multivitamines > High protein diet > Blood transfusion.
  • 39.
  • 40. First line Drugs Second line Drugs Isoniazid Rifampicin Pyrazinamide Ethambutol Streptomycin Thiacetazone Paraaminosalicylicacid Ethionamide Cycloserine Kanamycin Amikacin Capreomycin Fluroquinolones Macrolides Rifabutin
  • 41. Catagory Cat I Sputum positive new cases Sputum negative seriouslyill Seriously ill extrapulmonary PulmTB,TB meningitis,AbdominalTB, Bone & jointTB spinalTB. Cat II Treatmentdefalter Treatment failure Relapse Cat III Smear negative new pulm.TB with limitedparenchymal involvement. Tubercular lymphadenitis, skinTB. Cat IV Chronic or MDR cases
  • 42. Drug Mechanism of action WHO recommended doses Side effects Isoniazid Bacteriocidal, Inhibits the synthesis of mycolic acid 5 mg/kg daily dose. 10 mg/kg 3 per wk dose. Peri. neuropathy, behavior disorder, hepatitis, convulsion Rifampicin Bacteriocidal, Inhibit DNA depended RNA synthesis 10 mg/kg both daily & 3 per wk dose Hepatitis, pinkish staining of urine,saliva, flu like syndrome, rashes Pyrazinamid e Bacteriocidal, Inhibit mycolic acid synthesis 30-40 mg/kg Gouty arthritis, hepatotoxicity Ethambutol Bacteriostatic 15-20 mg/kg Retrobulbar neuritis, loss of vision, colour blindness. Streptomycin Bacteriocidal & bacteriostatic. Inhibits the protein synthesis 15-20 mg/kg Vestibular damage, deafness, nephrotoxicity, contact dermatitis.
  • 43.
  • 44.  DOTS- Directly observed treatment short course, means administering potent antimycobacterial regimens in an intermittent manner under direct supervision.  RNTCP- Revised national tuberculosis control programme based on the DOTS strategy in 1993 & gradually expanded & covered entire country under DOTS by 24th Mar2006.
  • 45. Catagory Initial phase Continuation phase Duration I 2 (HRZE)3 4 (HR)3 6 Months II 2 ( HRZES)3 + 1 (HRZE)3 5 (HRE)3 8 Months III 2 (HRZ)3 4 (HR)3 6 Months
  • 46.  Multi-drug Resistance (MDR) TB- Defined as resistance to Isoniazide & Rifampicin. Treatment of MDR –TB :- 6 months of initial phase with Streptomycin + Quinolone + Pyrazinamide + Ethambutol. 18 months of continuation phase with Ethionamide + Quinolone + Pyrazinamide + Ethambutol.
  • 47.  Corticosteroid :- Cortisone may help keep alive a moribund patient till theATT can take effect. Steroid is useful in patient with severe hypersensitivity reaction. A short course anabolic steroid may help a debilitated patientto be prepared for surgery. NSAID:- Used for relief of pain in early painful stage of disease.
  • 48.  Aspiration of joint.  Drainage of abscess.  Excision of sinus
  • 49.  INDICATION- > If response to conservative treatment is not favorable or outcome is unacceptable. > No sign of neurological recovery after trial of 3-4 wks therapy. > Neurological complication develop during conservative treatment. > Neuro deficit become worse on drugs & rest. > Recurrence of neurological complication. > Cervical abscess hampers in deglutition& respiration. > Advanced cases sphincter involvement, flaccid paralysis, severe flexor spasm.
  • 50. Surgery Indication Synvectomy & joint debridement Synovitis & Early arthitis Osteotomy Sound or unsound ankylosis in bad position Arthrodesis Ischiofemoral & Iliofemoral Adult with unsound ankylosis with active or healed disease Excisional Arthroplasty ( Girdlestone’s) Sound or unsound ankylosis.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.  Disappearance of all systemic & local features  Return of painless motion.  Repeated ESR is normal & no progression.  Remineralization & restoration of bony outline.  Resolution of edema & soft tissue swelling.  Bony alkylosis.
  • 57. Immuno-prophylaxis- 0.1 ml intradermal injection of live attenuated BCG vaccine proximal to the insertion of deltoid after birth. Give protection upto 80% & immunity lasts for 10-15 yrs. Chemoprophylaxis:- Combination of Isoniazid & Ethambutol once daily dose for 4-6 months. Indications- >Close contacts > Person with +ive tuberculin test . >TB infected person without active disease but develop high risk condition. > Patient with old inactive disease who are assessed to have received inadequate therapy.